Therapix Biosciences Ltd. (NASDAQ:TRPX) tinted gains of +3.52% (+0.16 points) to US$4.7. The volume of 0.07 Million shares climbed down over an trading activity of 125.99 Million shares. EPS ratio determined by looking at last 12 month figures is -2.36. Over the same time span, the stock marked US$7.69 as its best level and the lowest price reached was US$3.84. The corporation has a market cap of US$298.92 Million.
Therapix Biosciences Ltd. (NASDAQ:TRPX)’s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at 0 percent while most common profitability ratio return on investment (ROI) was 0 percent. The company’s institutional ownership is monitored at 0.39 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin.
IDT Corporation (NYSE:IDT) is worth US$165.89 Million and has recently risen 3.47% to US$6.26. The latest exchange of 0.26 Million shares is below its average trading activity of 259.79 Million shares. The day began at US$6.12 but the price moved to US$5.96 at one point during the trading and finally capitulating to a session high of US$6.34. The stock tapped a 52-week high of US$16.19 while the mean 12-month price target for the shares is US$18.
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 1.12, and a price to sales ratio of 0.11. For the past 5 years, the company’s revenue has grown -0.1%, while the company’s earnings per share has grown -24.1%. With an institutional ownership near 53.2%, it carries an earnings per share ratio of -0.57.